Lupin expects ANVISA clearance for beta-lactam cephalosporin APIs by September
ANVISA's suspension order dated May 13 states the reason of its action as "analysis considered unsatisfactory
Reacting to news…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.